Search

Pharmaron is holding a training webinar on June 20 on the importance of oligonucleotide drugs in modern medicine.

Among the most important emerging technologies are the manipulation of the microbiota, CAR-T cell therapies, and gene editing using CRISPR-Cas9, techniques that are positioning Spain as a benchmark in

The award recognizes the success of companies less than 10 years old that create wealth and employment in the Basque Country community.

The Phase IIa study ALICE evaluated the combination of iadademstat plus azacitidine in newly diagnosed, unfit patients with acute myeloid leukemia (AML). The combination showed substantial

BIO International Convention 2024. Congreso de la European Hematology Association (EHA) 2024. European Network to Cure ALS (ENCALS) 2024.

BCN HEALTH desarrolló un modelo de costes aplicable a nivel mundial para la atención de la talasemia.

Commission has approved up to €1 billion of State aid by six Member States: Belgium, France, Hungary, Italy, Slovakia, and Spain . Oryzon to validate epigenetic agents by applying a personalized

AseBio has organized, within the framework of the XVII Annual Conference of Biomedical Research Technology Platforms (Barcelona), the debate entitled “Collaboration and transfer: the DNA of biomedical

The Major Project of Common European Interest 'Med4Cure' will enable member states to support a total of 14 projects from 13 companies that will result in more than 70 collaborations, as well as 11

There are two important challenges for companies aiming to develop CGTs in mainstream indications.

Since 2023, the company has been certified as an Innovative SME.

Nearly 600 students from 12 schools in Barcelona city, L'Hospitalet de Llobregat, Montgat and Esplugues de Llobregat met during the month of May at Cibernàrium 22@ in Barcelona for the STEAM

Orphan Drug Designation is a special status granted by the FDA to drugs that are intended to treat rare diseases or conditions.

The reference forum of the biotechnology and life sciences industry in the European Atlantic Area celebrates its second edition in Vigo on June 12-13.

The final results of ATL-001, the biotech company's lead candidate, have shown that it is able to stabilize UROIIIS and recover its enzymatic activity.

The consulting firm specialized in the health sector will compare different quantitative data between patients suffering from these two types of infections in Spain.

The applied research and technological development center, TECNALIA , develops cutting-edge technologies that optimize processes in the agri-food sector.